tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Beta Bionics raises FY25 revenue view to over $96.5M from $88M-$93M prior

Consensus $91.4M. Sees FY25: Estimated 27% to 29% of new patient starts reimbursed through the PBP channel (previously 25% to 28%). Estimated gross margin of 54% to 55% (previously 52% to 55%).

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1